For years, branded drug costs have risen consistently. Yet, 2024 has brought a surprising shift with substantial decreases in wholesale acquisition costs. Our second webinar in a three-part series will explore the extraordinary depth of these price cuts in the context of historical data. Don't miss out: https://lnkd.in/eNb8iyti
IntegriChain
Pharmaceutical Manufacturing
Philadelphia, PA 76,827 followers
Data-Driven Commercialization
About us
IntegriChain helps Pharma manufacturers bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapy. We are doing this by building Pharma’s data-driven commercialization platform – from strategy to operational execution. Our unique focus on data, technology, consulting, and outsourcing helps connect the commercial, financial, and operational dimensions of drug access and profitability. IntegriChain enables pharmaceutical innovators to achieve better commercial outcomes by digitalizing daily and recurring business activities and by integrating data and operations across contracting, pricing, channel and distribution, and gross-to-net. We are backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Pharma. Additional companies in the IntegriChain family are Blue Fin Group, a leading strategy consultancy for the Pharma industry, and Federal Compliance Solutions, a leading Pharma advisory and managed services firm.
- Website
-
https://www.integrichain.com
External link for IntegriChain
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Philadelphia, PA
- Type
- Privately Held
- Founded
- 2005
- Specialties
- Life Sciences Channel Data and Analytics, Pharmaceutical Commercial Data Analytics, Business Intelligence, Advanced Analytics, Distribution Analytics, Patient Access, Market Access, Specialty Pharmaceuticals Analytics, Payer Analytics, Access Management, Government Pricing, Rebate Processing, Patient Services, Channel Data Aggregation, Inventory Analytics, Pharma Access, Pharma Distribution, Pharma Distribution Management, Master Data Management, Data Science, and Gross to net automation
Products
IntegriChain ICyte Platform
Pharmacy Management Systems
IntegriChain helps Pharma manufacturers bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapy. We are doing this by building Pharma’s data-driven commercialization platform – from strategy to operational execution. Our unique focus on data, technology, consulting, and outsourcing helps connect the commercial, financial, and operational dimensions of drug access and profitability. IntegriChain enables pharmaceutical innovators to achieve better commercial outcomes by digitalizing daily and recurring business activities and by integrating data and operations across contracting, pricing, channel and distribution, and gross-to-net.
Locations
-
Primary
8 Penn Center
1628 JFK Boulevard
Philadelphia, PA 19103, US
-
201 S Maple St
Ambler, Pennsylvania 19002, US
-
Pancard Club Rd
M Agile, Samarth Colony
Baner Pune, Maharashtra 411045, IN
Employees at IntegriChain
-
Gary Palgon, CISSP
Sales. Marketing and Operations Executive; Healthcare/Life Sciences; Analytics/Security/Cloud
-
Michael Kerman
Marketing and Technology Executive | Revenue Generator | Talent Developer
-
David Weiss
-
Vickie Kozhushchenko
CHRO, delivering HR Strategy, Peer & Leadership Coaching, Org Dynamics and Transformation. I bring strategic HR thinking to private equity-backed…
Updates
-
IntegriChain reposted this
As I've been writing about "Who Moved My Prescription?" this past year, it's nice to see this type of national media coverage on the problem with Retail Pharmacy and the potential hope. This is a 12:30 minute video and well worth watching to get a full picture of the situation. I'll give this journalism team credit - I usually see missing pieces or incorrectly drawn conclusions. This one is on the money! https://lnkd.in/eNmhD2WU
Why Walgreens And CVS Are Shutting Down Thousands Of Stores
https://www.youtube.com/
-
We are honored to have such an esteemed and elite group of healthcare policy experts join our Access Insights Conference. Thank you, William Sarraille, Alice Valder Curran, Meenakshi Datta, Albert Thigpen, and Stephen Morales for being part of our Executive Summit thought leadership program. Now in its 15th year and co-hosted by IntegriChain, Blue Fin Group, an IntegriChain Company, and Federal Compliance Solutions, an IntegriChain Company, the 3-day Access Insights is the only conference in the Pharma industry that is truly full commercialization across all the therapeutic areas, product archetypes, and benefit constructs. It's considered a can't-miss event for understanding the implications of recent and forward-looking public policy, commercial insurance, and how the sites of care, GPOs, and distribution channels contend or influence the market plus the latest in channel strategy and the patient journey, net revenue forecasting and planning, new product archetype commercialization and so much more. Check out our agenda and register today for Access Insights: https://lnkd.in/eYB8irsw
-
-
Tiffany Buker is a valued leader in our GTN SaaS & BPaaS team and one of our Circle of Excellence award winners in 2023! Her reliability is unparalleled, and her proactive approach to GTN forecasting and analytics translate to delighted customers. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/d6B_eKm
-
-
Discover the latest trends, strategies, and tactics for data-driven access and commercialization with Blue Fin Group, an IntegriChain Company, and Federal Compliance Solutions, an IntegriChain Company at the Access Insights Conference from October 14-16. Register today: https://lnkd.in/eYB8irsw
-
-
At IntegriChain, one of our core values is Quality. The relentless pursuit of quality is ubiquitous through our company: we strive for quality in all aspects of our work and delivery to our customers. If you share a dedication to quality, consider joining us. Great career opportunities are here: https://lnkd.in/e8pAhVRU
-
-
If you're looking to build a tech career using exciting cloud, data, and analytics technologies, consider joining our team. Learn more about careers at IntegriChain in the US and India here: https://lnkd.in/d6B_eKm
-
-
This month, Benjamin Fanelli, Jui Andhare, MBA, and Michael Gorokhovsky explore key industry issues. Learn more: https://lnkd.in/dSsv3623
-
-
Abhijit Bambal is a valued member of our data management team! Data is the backbone of decision-making for pharma commercialization. Abhijit ensures that critical access and distribution data is accurate, timely, and complete, enabling our customers to get life-changing medicines into the hands of patients. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/d6B_eKm
-
-
Traditionally, branded drug prices have followed a steady upward trajectory until generic competition emerges. However, 2024 has seen an unexpected surge in wholesale acquisition cost (WAC) reductions across the pharmaceutical industry. Our second webinar in a three-part series will delve into the unprecedented scale of these price cuts compared to historical trends. Register today: https://lnkd.in/eNb8iyti
-